News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Biogen Idec (BIIB) Slumps After Patient On Top-Selling Drug Dies     10/23/2014
Activist Investor Third Point Urges Amgen (AMGN) To Break Up     10/22/2014
Job Cuts Loom Over GlaxoSmithKline (GSK) As It Aims To Cut Costs; Eyes IPO Of HIV Unit     10/22/2014
Roche (RHHBY) To Spend $3.2 Billion On Basel Site Upgrade     10/22/2014
Johnson & Johnson (JNJ) Pledges $200 Million To Ebola, Will Begin Testing Vaccine In January 2015     10/22/2014
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses     10/22/2014
Viamet Pharmaceuticals Withdraws $75 Million IPO, Spins Off Cancer Program To Form Innocrin Pharmaceuticals     10/22/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts     10/22/2014
Regulus Therapeutics, Inc. (RGLS) Gets Seat At Hepatitis C Table With Impressive Phase 1 Results; Stock Up 99.98% At 12:54PM ET On Wednesday     10/22/2014
Actavis (ACT) Pays $40 Million Upfront; Snags Option To Buy Rhythm Health     10/22/2014
Vertex Pharmaceuticals (MA) (VRTX) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion     10/22/2014
Lexicon Pharmaceuticals, Inc. (LXRX), Ipsen (IPN.PA) Strike Licensing Deal Worth $145 Million     10/22/2014
Boston's Proteon Therapeutics, Inc. Files For $61 Million IPO     10/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda (TKPYY) Forge $55 Million Deal For Amitiza®     10/22/2014
AcelRx Pharmaceuticals (ACRX)'s Zalviso Met Primary Endpoint In Phase 3 Study     10/22/2014

Featured Stories
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/23/2014
GlaxoSmithKline (GSK)'s Rising Star Under Pressure As Drugs Falter     10/22/2014
What Happens When Chemists Don't Wash Their Hands     10/22/2014
Y Chromosome Linked To Cancer And Death Risk In Men, Uppsala Universitet Study     10/22/2014
Woman Finds Three-Inch Leech In Nose After South East Asia Trip     10/22/2014
Shift Workers Might Want To Skip High-Iron Foods At Night, University of Utah Study     10/22/2014
Recalled Dietary Supplements Found To Still Contain Banned Substances     10/22/2014
Walnuts May Help Protect Against Alzheimer’s Disease, New York State Institute For Basic Research In Developmental Disabilities Reveals     10/22/2014
Flu Vaccine May Hold Key To Preventing Heart Disease, Institute Vinca Study     10/22/2014
Should We Allow Scientists To Create Super-Viruses?     10/21/2014
Aspirin Shown To Benefit Schizophrenia Treatment, University Medical Center Utrecht Study     10/21/2014
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons     10/21/2014
Number Of Eggs A Woman Has Predicts Heart Attack Risk, University of California, San Francisco (UCSF) Study     10/21/2014
Cold Sore Virus Increases The Risk Of Dementia, Umea University Study     10/21/2014
Brain Scans Show Cause Of Seasonal Affective Disorder, University of Copenhagen Study     10/21/2014

More News
Videregen Welcomes Launch Of Angels In MedCity     10/22/2014
Santen Announces Positive Outcome Of The European Decentralized Procedure For Approval Of TAPTIQOM®     10/22/2014
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval     10/22/2014
Synageva BioPharma (GEVA) Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa     10/22/2014
Alkermes plc (ALKS)’ New Drug Application For Aripiprazole Lauroxil For Treatment Of Schizophrenia Accepted For Filing By U.S. FDA     10/22/2014
Relypsa, Inc. (RLYP) Submits New Drug Application To U.S. FDA Seeking Approval For Patiromer For Oral Suspension To Treat Hyperkalemia     10/22/2014
Repros Therapeutics Inc. (RPRX) Release: Results From Long-Term Study Of Androxal® Exhibit Positive Safety Profile     10/22/2014
Immune Pharmaceuticals, Inc. Release: New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease     10/22/2014
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Designation From European Medicines Agency For The Treatment Of Dravet Syndrome     10/22/2014
Oramed Pharmaceuticals Inc. (ORMP) Reports Positive Top-Line Data From U.S. Phase 2a Trial With Oral Insulin In Type 1 Diabetes     10/22/2014
Nuvo Research Inc. (NRI.TO) Completes WF10™ U.S. Market Study For Treatment Of Refractory Allergies     10/22/2014
Atara Biotherapeutics (ATRA) Doses First Patient In Phase 1 Clinical Study Of STM 434, An Activin Inhibitor     10/22/2014
iCo Therapeutics Inc. Announces Advancement Of Oral Amphotericin B Program     10/22/2014
Phosplatin Therapeutics Announces First Patients Enrolled In Phase I First-in-Human Clinical Trial In Solid Tumors     10/22/2014
University of Pittsburgh Study: Air Pollution Linked To Autism In Southwestern Pennsylvania     10/22/2014
BioNano Genomics's Irys System Adopted By Leading Genomics Centers For Comprehensive Detection Of Human Genome Structural Variation     10/22/2014
Ferring Pharmaceuticals To Acquire Marketing Rights For DDAVP® (desmopressin) Product Portfolio From Sanofi (SAN.PA)     10/22/2014
Masters Speciality Pharma Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin)     10/22/2014
Center For Connected Health And Daiichi Sankyo, Inc. (4568.t) Sign Agreement To Co-Develop A Mobile App To Support Patients With Atrial Fibrillation     10/22/2014
Foundation Medicine, Inc. (FMI) And WuXi PharmaTech Co., Ltd. Announce Strategic Collaboration To Offer Best-In-Class Comprehensive Genomic Profiling In China     10/22/2014
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies     10/22/2014
Xbrane Bioscience Signs Major Biosimilar Agreement With Global Indian Pharmaceutical Company     10/22/2014
PureMHC Release: Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets     10/22/2014
iBio, Inc. (IBIO) Expands Exclusive Product Collaboration With Novici Biotech     10/22/2014
Quest PharmaTech Inc. To Market And Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator Of COLD FX®, To Assist     10/22/2014
Daxor Corporation (DXR) Announces Research Agreement With Virginia Commonwealth University On Burn Patients     10/22/2014
Terumo BCT And OneBlood Partner In A Treatment Use Program Of An Investigational Device To Help Improve Blood Supply Safety     10/22/2014
UCB Group (UCBJF.PK) Deploys IMS Health Nexxus Suite And Intelligent Cloud To Drive Commercial Productivity, Accelerate Time To Insight     10/22/2014
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses     10/22/2014
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program     10/22/2014
Synthetic Biologics, Inc. (SYN) Announces Allowance Of Key U.S. Composition Of Matter Patent For C. Difficile Program     10/22/2014
Bioren, Inc. Announces Additional Orders For $1.7 Million     10/22/2014
Amgen (AMGN) Statement Regarding Third Point Investment     10/22/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program     10/22/2014
Mederi Therapeutics Inc. Release: Recent Clinical Study Data Confirms Efficacy Of Stretta Therapy - Spurs Additional Insurance Coverage And Financing Round     10/22/2014
TapImmune Inc. (TPIV) Provides Update On Polystart™ Vaccine Platform Applicable To Cancer And Infectious Disease     10/22/2014
EHE International Certifies Internal Medicine Consultants Of Northwest Indiana As Its Newest Partner     10/22/2014
Clovis Oncology (CLVS) To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6     10/22/2014
Flexion Therapeutics (FLXN) To Ring The Nasdaq Stock Market Opening Bel     10/22/2014
Metabolon's Platform For Clinical Triaging Of Inborn Errors Of Metabolism Verified By Baylor College of Medicine     10/22/2014
m2p-labs Supports Research Project In Synthetic Biology     10/22/2014
Esperion Therapeutics, Inc. (ESPR) Announces Closing Of Follow-On Public Offering And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock     10/22/2014
Radiant Sage Announces Corelab-in-a-Box Version 3.1     10/22/2014
Taconic Biosciences Launches New Health Standard     10/22/2014
New Class of MassCONNECT Startups Chosen Nixon Peabody LLP And Eli Lilly and Company (LLY) Sponsor     10/22/2014
Prima Biomed (PRR.AX) To Host Conference Call & Webcast To Discuss Acquisition Of Immutep S.A.     10/22/2014
Crown Bioscience, Inc. Release: Crown Bioscience Service Center Opening At David H. Murdock Research Institute     10/22/2014
Argos Therapeutics, Inc. (ARGS) Breaks Ground On State-Of-The-Art Biomanufacturing Facility In Research Triangle Park Area     10/22/2014
Akron Biotechnology, LLC Expanding To New, State-of-the-Art Biotechnology Facility     10/22/2014
Cytovance Biologics Inc. Announces the Launch Of Keystone Expression System™     10/22/2014
Abbott Laboratories (ABT) Reports Third-Quarter 2014 Results     10/22/2014
Abaxis, Inc. (ABAX) Reports Record Revenues For The Second Quarter Of Fiscal 2015     10/22/2014
Biogen Idec (BIIB) Third Quarter 2014 Revenues Increase 37% To $2.5 Billion     10/22/2014
Compugen Ltd. (CGEN) Third Quarter 2014 Conference Call Scheduled For Wednesday, October 29, 2014 At 10:00 AM ET     10/22/2014
Cubist Pharmaceuticals, Inc. (CBST) Reports Third Quarter 2014 Financial Results     10/22/2014
Cerus Corporation (CERS) To Release Third Quarter 2014 Results On November 4, 2014     10/22/2014
ChemoCentryx, Inc. (CCXI) To Hold Third Quarter 2014 Financial Results Conference Call On Wednesday, November 5, 2014     10/22/2014
Cempra Pharmaceuticals, Inc. To Report Third Quarter 2014 Financial Results And Host Webcast And Conference Call On October 29, 2014     10/22/2014
Cumberland Pharmaceuticals (CPIX) To Announce Third Quarter 2014 Financial Results On November 4, 2014     10/22/2014
Gilead Sciences, Inc. (GILD) To Release Third Quarter 2014 Financial Results On Tuesday, October 28, 2014     10/22/2014
ICON Reports Third Quarter 2014 And Increases Earnings Guidance     10/22/2014
Momenta Pharmaceuticals, Inc. (MNTA) Announces Date Of Third Quarter 2014 Financial Results Conference Call And Webcast     10/22/2014
OXiGENE (OXGN) Announces Third Quarter 2014 Earnings Conference Call And Webcast     10/22/2014
Orexo AB (ORXOF): Interim Report January-September 2014     10/22/2014
Radius (RDUS) To Announce Third Quarter 2014 Financial Results, Host Conference Call And Live Webcast On Nov 11, 2014     10/22/2014
St. Jude Medical (STJ) Announces Fourth Quarter Dividend     10/22/2014
TRANSGENE (ENX:TNG) Announces Third Quarter 2014 Financial Results     10/22/2014
Thermo Fisher Scientific (TMO) Reports Third Quarter 2014 Results     10/22/2014
The Medicines Company (MDCO) Reports Third Quarter And First Nine Months 2014 Results     10/22/2014
aTyr Pharma Inc. Appoints John C. McKew, Ph.D., As Vice President, Research     10/22/2014
ProNAi Therapeutics, Inc. Strengthens Senior Management Team To Advance DNAi®-based Oncology Therapeutics     10/22/2014
Celltrion, Inc. (068270.KQ): Experts Share Their “Real World” Experience Of Treating People With Inflammatory Bowel Disease (IBD) With Biosimilar Anti-Tnfa Monoclonal Antibody (Mab)     10/22/2014
Novo Nordisk Partners With Award-Winning Youtube Star Michael Stevens On New Online Videos For Diabetes Education     10/22/2014
Glaucoma Foundation Holds Third Scientific Think Tank On Exfoliation Syndrome     10/22/2014
Acceleron Pharma Announces Educational Webcast On Chronic Kidney Disease - Mineral And Bone Disorder     10/22/2014
Creative Animodel Updated TALENs Services: Customized For Biotech Researchers And Developers     10/22/2014
CD Genomics Release: FFPE Samples Sequencing For Genotyping Studies     10/22/2014
GlaxoSmithKline (GSK) CEO And CFO Interviewed On 2014 Q3 Results     10/22/2014
Opexa Therapeutics (OPXA) Supports National Multiple Sclerosis Society And Walk MS     10/22/2014
Colorado BioScience Association Announces Finalists For 2014 ‘Company Of The Year’ And ‘Rising Star’ Of The Year Awards     10/22/2014
Frost & Sullivan Recognises Europe's Top Achievers At Excellence In Best Practices Awards Banquet In Monaco     10/22/2014
Fogarty Institute for Innovation Release: Dr. Thomas J Fogarty Awarded Presidential National Medal Of Technology And Innovation     10/22/2014
UCB, Inc. (UCBJF.PK)-sponsored Data On Cimzia® (certolizumab pegol) To Be Highlighted At American College of Gastroenterology 2014 Annual Scientific Meeting     10/22/2014
GenomOncology President And CEO Manuel Glynias To Present At Cleveland Clinic’s 12th Annual Medical Innovation Summit     10/22/2014
Epilepsy Foundation Release: Conference Highlights Sudden Unexpected Death In Epilepsy (SUDEP)     10/22/2014
The 65th Annual Meeting Of The American Association For The Study Of Liver Diseases     10/22/2014
Reproductive Medicine Associates Release: New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies     10/22/2014
Gateway Analytical To Present On Formulation Development And Establishing Bioequivalence In Drug Products     10/22/2014
Cellular Dynamics International To Present At The 2014 Medical Innovation Summit     10/22/2014
RedHill Biopharma Ltd. (RDHL) To Present At The 20th Annual BIO-Europe International Partnering Conference     10/22/2014
Immunomedics, Inc. (IMMU) To Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates At Upcoming Conferences     10/22/2014
HealthMap Co-Founder And Prominent Epidemiologist Dr. John Brownstein To Deliver Keynote At 2014 mHealth Summit Focused On Ebola Outbreak, Epidemics And Public Health Surveillance     10/22/2014
Novalis: Industry Leaders Present The Technical And Clinical Validation Of Integrated Surgery And Radiosurgery For Benign Brain Tumors     10/22/2014
McKesson Corporation To Present At The 2014 Credit Suisse Healthcare Conference     10/22/2014
BioFlorida, Inc. Conference Promotes Collaboration, Growth And Innovation In Florida’s Life Sciences Industry     10/22/2014
Leading Biobased Business Experts To Discuss What’s Next In Industrial Biotechnology And The Bioeconomy At The Biotechnology Industry Organization (BIO) 2014 Pacific Rim Summit     10/22/2014
Acceleron Pharma Announces Educational Webcast On Chronic Kidney Disease - Mineral And Bone Disorder     10/22/2014
Theorem Clinical Research To Present Webinar On Best Practices For Conducting Early-Phase Oncology Trials     10/22/2014

Career Tips
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014
Get A Biotech Job By Thinking Like A Hiring Manager     10/9/2014
7 Deadly Interview Sins     10/9/2014
3 Ways To Uncover A Hidden Job     10/9/2014
3 Crucial Areas To Ask About During The Interview     10/9/2014
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation (LMNX)     9/26/2014
The One Job Search Technique That Eliminates Your Competition     9/25/2014
The Secret To Being The Only Person Applying For the Job     9/25/2014
5 Golden Rules For Negotiating Salary     9/25/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->